कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
VTRS | NASDAQ | USD | रियल टाइम | |
1VTRS | मिलान | EUR | रियल टाइम | |
VIA1 | फ़्रंकफ़र्ट | EUR | देरी | |
VTRSI | विएना | EUR | रियल टाइम |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Mark W. Parrish | 67 | 2009 | Independent Vice Chairman & Lead Independent Director |
Melina E. Higgins | 55 | 2013 | Independent Non-Executive Chairman |
Scott Andrew Smith | 61 | 2022 | CEO & Director |
Harry A. Korman | 67 | 2001 | Independent Non-Executive Director |
Wyllie Don Cornwell | 76 | 2020 | Independent Director |
James Marshall Kilts | 76 | 2020 | Independent Director |
Elisha Wade Finney | 63 | 2022 | Independent Director |
Leo Groothuis | 52 | 2023 | Independent Director |
Robert J. Coury | 63 | 2002 | Chairman Emeritus & Senior Strategic Advisor |
Rajiv Malik | 63 | 2007 | Director |
JoEllen Lyons Dillon | 60 | 2014 | Independent Non-Executive Director |
Richard A. Mark | 70 | 2020 | Independent Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है